Hin Sang Group (International) Holding Co. Ltd. (6893) AI Stock Analysis

• Market Cap: HK$191.06M
• Dividend Yield: N/A
• Average Volume (3M): 104.73K
• Price to Earnings (P/E): ―
• Beta (1Y): 0.39
• Revenue Growth: -0.79%
• EPS Growth: -34.52%
• Country: HK
• Employees: 230
• Sector: Consumer Defensive
• Sector Strength: 42
• Industry: Household & Personal Products
• EPS (TTM): -0.03
• Shares Outstanding: 1,091,796,000
• 10 Day Avg. Volume: 173,600
• 30 Day Avg. Volume: 104,733
• PEG Ratio: N/A
• Price to Book (P/B): N/A
• Price to Sales (P/S): N/A
• P/FCF Ratio: N/A
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: N/A
• Price Target Upside: N/A
• Rating Consensus: N/A
• Number of Analyst Covering: 0

• Rating: 41 Neutral
• Price Target: HK$0.00 ▼(-100.00% Downside)

The overall stock score is primarily influenced by the company's weak financial performance, characterized by ongoing losses and high leverage. Technical analysis indicates a bearish trend, with the stock trading below key moving averages and nearing oversold conditions. Valuation metrics are unfavorable, with a negative P/E ratio and no dividend yield, further impacting the stock's attractiveness.

Hin Sang Group (International) Holding Co. Ltd. Business Overview & Revenue Model

Company Description

Hin Sang Group (International) Holding Co. Ltd. (6893) is a Hong Kong-based company primarily engaged in the manufacturing and retail of traditional Chinese medicinal products and health supplements. The company operates in the health and wellness sector, offering a wide range of products that include herbal remedies, dietary supplements, and wellness foods. Hin Sang Group emphasizes the use of natural ingredients and traditional Chinese medicine principles, catering to both local and international markets.

How the Company Makes Money

Hin Sang Group generates revenue primarily through the sale of its health and wellness products. The company has a diversified revenue model that includes retail sales through its own branded stores, e-commerce platforms, and distribution partnerships with various retailers. Key revenue streams come from the sale of herbal products, health supplements, and related merchandise. Additionally, Hin Sang Group may benefit from strategic partnerships with health practitioners and wellness centers, which can enhance brand visibility and customer reach. The company's focus on quality and adherence to traditional Chinese medicine principles also allows it to position its products at a premium price point, contributing to higher profit margins.

Hin Sang Group (International) Holding Co. Ltd. Financial Statement Overview

Summary

Hin Sang Group faces significant financial challenges, with ongoing losses and high leverage. While there is some revenue growth, profitability and cash flow management remain critical issues. The company needs to focus on improving operational efficiency and reducing debt to enhance financial stability.

Income Statement

Hin Sang Group has shown some revenue growth, but profitability remains a significant concern. The gross profit margin is relatively healthy, but the company has been consistently operating at a net loss, with negative EBIT and EBITDA margins. This indicates challenges in managing operational costs and achieving profitability.

Balance Sheet

The company's balance sheet reveals high leverage, with a debt-to-equity ratio above 2, indicating potential financial risk. The return on equity is negative, reflecting ongoing losses. However, the equity ratio is moderate, suggesting some stability in asset financing.

Cash Flow

Cash flow analysis shows negative free cash flow growth and a low operating cash flow to net income ratio, highlighting cash management issues. The free cash flow to net income ratio is significantly negative, indicating that the company is not generating sufficient cash from its operations to cover its losses.

Breakdown	TTM	Dec 2024	Dec 2023	Dec 2022	Dec 2021	Dec 2020
Income Statement
Total Revenue	86.51M	91.89M	92.62M	81.46M	120.55M	119.44M
Gross Profit	54.82M	60.28M	57.41M	38.84M	69.08M	68.79M
EBITDA	-22.92M	-16.57M	-3.58M	-17.05M	21.82M	-4.35M
Net Income	-45.13M	-49.36M	-36.70M	-49.49M	-11.91M	-31.95M
Balance Sheet
Total Assets	599.56M	555.73M	587.85M	618.28M	693.77M	711.82M
Cash, Cash Equivalents and Short-Term Investments	15.12M	19.87M	19.35M	12.44M	17.58M	18.05M
Total Debt	339.45M	344.41M	321.10M	318.42M	320.91M	345.50M
Total Liabilities	400.73M	399.61M	378.52M	378.37M	391.97M	392.24M
Stockholders Equity	198.73M	155.28M	208.84M	239.38M	301.59M	318.28M
Cash Flow
Free Cash Flow	-11.17M	-4.27M	5.62M	-3.79M	23.65M	-53.16M
Operating Cash Flow	-10.51M	638.00K	6.29M	402.00K	23.99M	10.65M
Investing Cash Flow	-661.00K	-4.73M	-585.00K	-2.09M	15.20M	-63.72M
Financing Cash Flow	16.05M	6.27M	-4.87M	-93.00K	-41.67M	55.34M

Hin Sang Group (International) Holding Co. Ltd. Technical Analysis

• Technical Analysis Sentiment: Negative
• Last Price: 0.19
• 50DMA: Negative
• 100DMA: Negative
• 200DMA: Negative
• MACD: Positive
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For HK:6893, the sentiment is Negative. The current price of 0.19 is below the 20-day moving average (MA) of 0.20, below the 50-day MA of 0.22, and below the 200-day MA of 0.21, indicating a bearish trend. The MACD of >-0.01 indicates Positive momentum. The RSI at 32.15 is Neutral, neither overbought nor oversold. The STOCH value of 29.37 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for HK:6893.

Hin Sang Group (International) Holding Co. Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
1455	76 Outperform	HK$300.46M	7.21	9.60%	6.55%	1.60%	7.59%
1962	64 Neutral	HK$298.84M	9.96	3.77%	10.67%	-6.67%	-29.55%
Sector *	62 Neutral	$20.33B	14.63	-3.31%	3.23%	1.93%	-12.26%
2023	62 Neutral	HK$363.93M	6.40	10.92%	―	11.10%	-4.38%
3332	56 Neutral	HK$664.25M	21.93	3.92%	―	-0.92%	-71.88%
6893	41 Neutral	HK$191.06M	―	-27.11%	―	-0.79%	-34.52%

Hin Sang Group (International) Holding Co. Ltd. Corporate Events

Hin Sang Group’s AGM Resolutions Unanimously Approved

Hin Sang Group (International) Holding Co. Ltd. announced that all proposed resolutions at its annual general meeting held on September 25, 2025, were unanimously approved by shareholders. This includes the re-election of directors, authorization of directors’ remuneration, re-appointment of auditors, and granting of mandates for share repurchase and issuance, indicating strong shareholder support and potentially enhancing the company’s operational flexibility and strategic positioning.

The most recent analyst rating on (HK:6893) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Hin Sang Group (International) Holding Co. Ltd. stock, see the HK:6893 Stock Forecast page.

Hin Sang Group AGM Rescheduling Due to Weather Concerns

Hin Sang Group (International) Holding Co. Ltd. has announced potential changes to its Annual General Meeting (AGM) schedule due to the approach of a tropical cyclone in Hong Kong. If severe weather conditions persist, the AGM originally set for 25 September 2025 will be rescheduled to 29 September 2025. All resolutions and proxy arrangements will remain unchanged, and shareholders are advised to exercise caution if attending under adverse weather conditions.

The most recent analyst rating on (HK:6893) stock is a Hold with a HK$0.50 price target. To see the full list of analyst forecasts on Hin Sang Group (International) Holding Co. Ltd. stock, see the HK:6893 Stock Forecast page.

Hin Sang Group Announces AGM and Share Repurchase Plan

Hin Sang Group (International) Holding Co. Ltd. has announced its annual general meeting scheduled for September 25, 2025. Key agenda items include the re-election of independent non-executive directors, authorization for the board to set directors’ remuneration, and the re-appointment of auditors. Additionally, the company seeks approval for a share repurchase program, allowing the repurchase of up to 10% of its issued shares, which could impact the company’s stock liquidity and shareholder value.